[The survey and cross-sectional analysis of palliative radiotherapy for bone metastases to facilitate its proper use in cancer patients]

Ahn YC, Shin S, Kim JH, Lee YJ, Park JA, Lee SW, Sheen SS, Park HC, Yoon SM, Kim HJ, Koom WS
Record ID 32014000411
Korean
Original Title: 암환자 증상완화를 위한 방사선 치료의 적정 이용률 제고를 위한 연구
Authors' recommendations: This study confirmed through a systematic literature review that the single-fraction method for the palliative treatment of patients with bone metastases had a similar effect to multiple fractions in producing pain relief. However, through a questionnaire survey and a retrospective study, it was found that multiple fractions were preferred to the single-fraction method in Korea, which was contrary to the evidence from the systematic review. As the first step towards narrowing the differences between the evidence and practice patterns, we organized a panel discussion to share the study results and to exchange expert opinions in various specialties on Nov. 27, 2009, as a part of this study. Various opinions on the reasons for the differences and ideas to narrow these differences were discussed. The necessity for conducting a prospective randomized clinical trial and for preparing practice guidelines that took into account various clinical settings was also raised.
Details
Project Status: Completed
Year Published: 2010
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: South Korea
MeSH Terms
  • Humans
  • Neoplasm Metastasis
  • Bone Neoplasms
  • Palliative Care
  • Radiotherapy Dosage
Contact
Organisation Name: National Evidence-based healthcare Collaborating Agency
Contact Address: National Evidence-based Healthcare Collaborating Agency (NECA), 3~5F Health and Welfare Social Administration B/D, 400 Neungdong-ro, Gwangjin-gu, Seoul, Korea.
Contact Name: int@neca.re.kr
Contact Email: int@neca.re.kr
Copyright: National Evidence-based Healthcare Collaborating Agency (NECA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.